1. Home
  2. OWLT vs BOLD Comparison

OWLT vs BOLD Comparison

Compare OWLT & BOLD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Owlet Inc.

OWLT

Owlet Inc.

N/A

Current Price

$5.06

Market Cap

148.4M

Sector

Health Care

ML Signal

N/A

Logo Boundless Bio Inc.

BOLD

Boundless Bio Inc.

N/A

Current Price

$2.60

Market Cap

60.8M

Sector

N/A

ML Signal

N/A

Company Overview

Basic Information
Metric
OWLT
BOLD
Founded
2013
2018
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Electromedical & Electrotherapeutic Apparatus
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
148.4M
60.8M
IPO Year
2020
2024

Fundamental Metrics

Financial Performance
Metric
OWLT
BOLD
Price
$5.06
$2.60
Analyst Decision
Strong Buy
Analyst Count
5
0
Target Price
★ $13.00
N/A
AVG Volume (30 Days)
★ 162.2K
110.7K
Earning Date
11-12-2026
11-04-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
★ 32.47
EPS
★ N/A
N/A
Revenue
★ $105,708,000.00
N/A
Revenue This Year
$13.29
N/A
Revenue Next Year
$20.39
N/A
P/E Ratio
★ N/A
N/A
Revenue Growth
★ 35.43
N/A
52 Week Low
$4.19
$0.96
52 Week High
$16.94
$3.16

Technical Indicators

Market Signals
Indicator
OWLT
BOLD
Relative Strength Index (RSI) 55.04 30.09
Support Level $5.18 $2.39
Resistance Level $5.57 $2.64
Average True Range (ATR) 0.24 0.10
MACD 0.07 -0.04
Stochastic Oscillator 72.48 13.73

Price Performance

Historical Comparison
OWLT
BOLD

About OWLT Owlet Inc.

Owlet Inc is engaged in providing a digital parenting platform that aims to give parents real-time data and insights to help parents feel more calm and confident. Its diversified portfolio of products includes Owlet Smart Sock, the first baby monitor to track an infant's oxygen levels, heart rate, and sleep trends; the Owlet Cam, which turns any smartphone into a baby monitor with high-definition clarity; the Owlet Monitor Duo, which offers the intelligence of the Owlet Smart Sock paired with the Owlet Cam; and Owlet Dream Lab, an interactive online program designed to be a parent's guide to building healthy sleep habits for their infants.

About BOLD Boundless Bio Inc.

Boundless Bio Inc is a clinical-stage oncology company. It is focused on developing cancer therapeutics that address the unmet need in patients with oncogene-amplified tumors by targeting extrachromosomal DNA (ecDNA), a root cause of oncogene amplification observed in cancer patients. Using its proprietary Spyglass platform, the company identifies targets essential for ecDNA functionality, then designs and develops small-molecule drugs called ecDNA-directed therapies (ecDTx) to inhibit those targets. Its main ecDTx candidate under development, BBI-940, is a novel, oral, selective degrader that has demonstrated potent anti-tumor activity across a range of cancer cell lines and mouse xenograft models, including single-agent tumor regressions.

Share on Social Networks: